Columbia Laboratories To Discuss Second Quarter 2013 Financial Results On August 7 Conference Call

Columbia Laboratories, Inc. (NasdaqCM: CBRX) will hold a conference call on August 7, 2013, to discuss financial results of the second quarter ended June 30, 2013. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call.
      Date:       Wednesday, August 7, 2013
Time: 11:00 am EDT
Dial-in numbers: (877) 303-9483 (U.S. & Canada) or (760) 666-3584
Conference ID:

21285162
Live webcast:

www.columbialabs.com, under 'Investor'

The teleconference replay will be available two hours after completion through Monday, August 12, 2013, at (855) 859-2056 (U.S. & Canada) or (404) 537-3406. The conference ID for the replay is 21285162. The archived webcast will be available for one year on the Company's website, www.columbialabs.com, in the 'Investor' section under 'Events'.

About Columbia Laboratories

Columbia Laboratories, Inc. is a publicly traded specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications. For more information, please visit www.columbialabs.com.

If you liked this article you might like

Biotech Stocks Triggering Breakout Trades: Columbia Labs

Healthcare Sector: High Quality Stocks At A Great Value

Columbia Laboratories's CEO Discusses Q2 2012 Results - Earnings Call Transcript

A Classic Biotech Long Shot

Columbia Stock Gaps Down On Today's Open (CBRX)